Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 30.98% is 160% above its 5-year average of -51.33%, near the high end of its 5-year range (-1146.29%–381.81%).
271.53% above its 12-month average of 8.34%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 60.53%.
NET PROFIT MARGIN
30.98%
NET PROFIT MARGIN AVG TTM
8.34%
NET PROFIT MARGIN AVG 3Y
-0.54%
NET PROFIT MARGIN AVG 5Y
-51.33%
NET PROFIT MARGIN AVG 10Y
-40.97%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+271.53%
CURRENT VS 3Y AVG
+5829.13%
CURRENT VS 5Y AVG
+160.36%
CURRENT VS 10Y AVG
+175.62%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 525 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Cronos Group Inc.
Market Cap
$1.23B
Net Profit Margin
30.98%
TTM Avg
8.34%
3Y Avg
-0.54%
5Y Avg
-51.33%
Market Cap
$1.23B
Net Profit Margin
-0.26%
TTM Avg
-1.90%
3Y Avg
-3.13%
5Y Avg
-3.39%
Market Cap
$1.24B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.17B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.16B
Net Profit Margin
2.07%
TTM Avg
2.94%
3Y Avg
0.11%
5Y Avg
-9.38%
Market Cap
$1.14B
Net Profit Margin
-5.43%
TTM Avg
-0.76%
3Y Avg
-19.17%
5Y Avg
-21.06%
Market Cap
$1.14B
Net Profit Margin
-13.51%
TTM Avg
-5.33%
3Y Avg
-11.32%
5Y Avg
-12.84%
Market Cap
$1.33B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.23B | 30.98% | 8.34% | -0.54% | -51.33% |
| Innovage Holding Corp. (INNV)vs › | $1.23B | -0.26% | -1.90% | -3.13% | -3.39% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.24B | 0.00% | 0.00% | 0.00% | 0.00% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.17B | 0.00% | 0.00% | 0.00% | 0.00% |
| Kardigan, Inc. (KARD)vs › | $1.29B | 0.00% | 0.00% | 0.00% | 0.00% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | 2.07% | 2.94% | 0.11% | -9.38% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.14B | -5.43% | -0.76% | -19.17% | -21.06% |
| Harrow Health, Inc. (HROW)vs › | $1.14B | -13.51% | -5.33% | -11.32% | -12.84% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $1.33B | 0.00% | 0.00% | 0.00% | 0.00% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.13B | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-12.0%
Net Profit Margin
31.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 60.53% |
| 2026-03-31 | 30.42% |
| 2025-12-31 | -1.99% |
| 2025-09-30 | 71.43% |
| 2025-06-30 | -118.70% |
| 2025-03-31 | 18.98% |
| 2024-12-31 | 144.32% |
| 2024-09-30 | 24.37% |
| 2024-06-30 | -31.54% |
| 2024-03-31 | -8.86% |
| 2023-12-31 | -187.29% |
| 2023-09-30 | -6.63% |
| 2023-06-30 | -43.95% |
| 2023-03-31 | -98.33% |
| 2022-12-31 | -358.03% |
| 2022-09-30 | -181.25% |
| 2022-06-30 | -93.61% |
| 2022-03-31 | -143.75% |
| 2021-12-31 | -518.07% |
| 2021-09-30 | 381.81% |
| 2021-06-30 | -1146.29% |
| 2021-03-31 | -1279.14% |
| 2020-12-31 | -652.55% |
| 2020-09-30 | 607.79% |
| 2020-06-30 | -797.33% |
| 2020-03-31 | 901.80% |
| 2019-12-31 | 863.68% |
| 2019-09-30 | 10492.26% |
| 2019-06-30 | 1852.80% |
| 2019-03-31 | 10472.35% |
| 2018-12-31 | -217.99% |
| 2018-09-30 | -147.91% |
| 2018-06-30 | 21.30% |
| 2018-03-31 | -35.66% |
| 2017-12-31 | 130.46% |
| 2017-09-30 | 83.49% |
| 2017-06-30 | 27.06% |
| 2017-03-31 | -164.81% |
| 2016-12-31 | 228.10% |
| 2016-09-30 | -242.36% |
| 2016-06-30 | 108.37% |
| 2016-03-31 | 3312.30% |
| 2015-12-31 | 43.77% |
| 2015-09-30 | 673.62% |
| 2015-06-30 | 547.88% |
| 2015-03-31 | 348.57% |
| 2014-12-31 | 1046.20% |
| 2014-09-30 | 27.89% |
| 2014-06-30 | -71.93% |
| 2014-03-31 | 321.78% |
| 2013-12-31 | 282.17% |
| 2013-09-30 | 290.84% |
| 2013-06-30 | 0.00% |
